-
Loading metrics
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
- Per Björk,
- Anders Björk,
- Thomas Vogl,
- Martin Stenström,
- David Liberg,
- Anders Olsson,
- Johannes Roth,
- Fredrik Ivars,
- Tomas Leanderson
x
- Published: April 28, 2009
- https://doi.org/10.1371/journal.pbio.1000097